ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

October 23, 1998

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

October 13, 2000

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Lymphoma Research Foundation names William Hawley president.

January 23, 2004

Coordination, Funding Lacking In National Cancer Program: Report

October 7, 1994

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977